Org Partners LLC Medicenna Therapeutics Corp. Transaction History
Org Partners LLC
- $644 Million
- Q2 2024
A detailed history of Org Partners LLC transactions in Medicenna Therapeutics Corp. stock. As of the latest transaction made, Org Partners LLC holds 100,000 shares of MDNA stock, worth $31,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$31,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MDNA
# of Institutions
3Shares Held
838KCall Options Held
0Put Options Held
0About Medicenna Therapeutics Corp.
- Ticker MDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,637,504
- Market Cap $21.6M
- Description
- Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...